EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A High-Throughput Assay for In Vitro Determination of Release Factor-Dependent Peptide Release from a Pretermination Complex by Fluorescence Anisotropy—Application to Nonsense Suppressor Screening and Mechanistic Studies

Mikel D Ghelfi, Saleem Y Bhat iD, Hong Li, Barry S Cooperman iD

Biomolecules · 2023

DOI: 10.3390/biom13020242 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2023. Verfasst von Mikel D Ghelfi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Pennsylvania, Philadelphia, PA 19104, USA. Hauptthemen laut MEDLINE: Codon, Nonsense, Protein Biosynthesis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, PTC Therapeutics, Cystic Fibrosis Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Premature termination codons (PTCs) account for ~12% of all human disease mutations. Translation readthrough-inducing drugs (TRIDs) are prominent among the several therapeutic approaches being used to overcome PTCs. Ataluren is the only TRID that has been approved for treating patients suffering from a PTC disease, Duchenne muscular dystrophy, but it gives variable readthrough results in cells isolated from patients suffering from other PTC diseases. We recently elucidated ataluren’s mechanism of action as a competitive inhibitor of release factor complex (RFC) catalysis of premature termination and identified ataluren’s binding sites on the ribosome responsible for such an inhibition. These results suggest the possibility of discovering new TRIDs, which would retain ataluren’s low toxicity while displaying greater potency and generality in stimulating readthrough via the inhibition of termination. Here we present a detailed description of a new in vitro plate reader assay that we are using both to screen small compound libraries for the inhibition of RFC-dependent peptide release and to better understand the influence of termination codon identity and sequence context on RFC activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Codon, NonsenseProtein BiosynthesisHumansCodon, TerminatorMutationPeptides

Stichwörter der Autor:innen

atalurenhigh-throughput screening (HTS)premature termination codonreadthroughterminationtranslation readthrough-inducing drug (TRID)

Substanzen

Codon, NonsenseCodon, TerminatorPeptides

Autor:innen und Institutionen

  • Department of Chemistry, University of Pennsylvania, Philadelphia, PA 19104, USA.

ORCID-Profile: Saleem Y Bhat, Barry S Cooperman

Förderung

  • NIGMS NIH HHS
  • PTC Therapeutics
  • Cystic Fibrosis Foundation

Zitieren

APA

Ghelfi, M. D., Bhat, S. Y., Li, H., & Cooperman, B. S. (2023). A High-Throughput Assay for In Vitro Determination of Release Factor-Dependent Peptide Release from a Pretermination Complex by Fluorescence Anisotropy—Application to Nonsense Suppressor Screening and Mechanistic Studies. Biomolecules. https://doi.org/10.3390/biom13020242

Vancouver

Ghelfi MD, Bhat SY, Li H, Cooperman BS. A High-Throughput Assay for In Vitro Determination of Release Factor-Dependent Peptide Release from a Pretermination Complex by Fluorescence Anisotropy—Application to Nonsense Suppressor Screening and Mechanistic Studies. Biomolecules. 2023. doi:10.3390/biom13020242

BibTeX
@article{Ghelfi2023,
  author = {Ghelfi, Mikel D and Bhat, Saleem Y and Li, Hong and Cooperman, Barry S},
  title = {A High-Throughput Assay for In Vitro Determination of Release Factor-Dependent Peptide Release from a Pretermination Complex by Fluorescence Anisotropy—Application to Nonsense Suppressor Screening and Mechanistic Studies},
  journal = {Biomolecules},
  year = {2023},
  doi = {10.3390/biom13020242}
}
Kostenlos starten →